SIRT2 and hepatocellular carcinoma: In the specific context of hepatocellular carcinoma, SIRT2 regulates Akt deacetylation and activity, thus promoting glycogen synthase kinase-3β (GSK-3β)/β-catenin signaling and causing EMT and cell migration [211].